Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05408507 · ClinicalTrials.gov registry record · NA

Care Planning Framework in Advanced Cancer (ABC123)

A NA study of Advanced Cancer, sponsored by University of Colorado, Denver.

Active
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT05408507: Active NA study of Advanced Cancer, sponsored by University of Colorado, Denver.

NCT05408507 is a NA study of Advanced Cancer that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 70 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05408507, a NA study of Advanced Cancer, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Pilot study assessing the feasibility and acceptability of the ABC123 framework, as well as goal concordance between patient and clinician stated goals. Patients \>60 years old with recently diagnosed advanced, incurable cancer in for a first consultation at a participating medical oncology clinic. The team will pilot test the ABC123 framework delivery by an advanced practice provider working with a medical oncologist to inform the overall care planning process. This framework will routinely incorporate and implement existing resources from these 3 transdisciplinary tenets (geriatric, oncology, and palliative medicine) into initial care planning in a patient-centered manner. The team will follow patients from initial care planning to 6 months post-intervention and assess additional stakeholder feedback on barriers and facilitators to implementation.

Primary Outcome

Recruitment (proportion of those approached who actually enroll)

Conditions Studied

Interventions

  • BEHAVIORAL ABC123 Framework

Study Locations (1)

Colorado

  • University of Colorado Cancer Center - Aurora

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2022-02-15
Est. Completion 2027-12
Phase NA
University of Colorado, Denver

1,283 total trials

What the registry record for NCT05408507 still lists

NCT05408507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 1 intervention - of which ABC123 Framework is the first listed.

NCT05408507 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05408507 about?

NCT05408507 is a clinical study titled "Care Planning Framework in Advanced Cancer (ABC123)". Pilot study assessing the feasibility and acceptability of the ABC123 framework, as well as goal concordance between patient and clinician stated goals. Patients \>60 years old with recently diagnosed advanced, incurable cancer in for a first consultation at a participating medical oncology clinic. ...

What is the current status of trial NCT05408507?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2022-02-15. Estimated completion is 2027-12.

What conditions does trial NCT05408507 study?

This clinical trial studies the following conditions: Advanced Cancer.

What interventions are being tested in trial NCT05408507?

The interventions under investigation include: ABC123 Framework (BEHAVIORAL).

Who is sponsoring clinical trial NCT05408507?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05408507 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05408507's enrollment target sits among peer trials

70 72nd of 122 higher than 50 of 122 other Advanced Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05408507, the US trial registry maintained by the National Library of Medicine. NCT05408507 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.